Mark DePristo
Founder at BigHat Biosciences, Inc.
Profile
Mark DePristo is the founder and current Chief Executive Officer & Director of BigHat Biosciences, Inc. which is founded in 2019.
He previously worked as a Senior Scientist at both Massachusetts Institute of Technology and The Broad Institute, Inc. Additionally, he worked as a Vice President-Informatics at SynapDx Corp.
Dr. DePristo holds a doctorate degree from the University of Cambridge and an undergraduate degree from Northwestern University.
Mark DePristo active positions
| Companies | Position | Start |
|---|---|---|
BigHat Biosciences, Inc.
 BigHat Biosciences, Inc. Pharmaceuticals: MajorHealth Technology BigHat Biosciences, Inc. operates as an early-stage biotechnology company. The firm focuses on designing antibodies and other therapeutic proteins using artificial intelligence and machine learning techniques. The company was founded by Mark DePristo and Peyton Greenside in 2019 and is headquartered in San Carlos, CA. | Founder | 2018-12-31 |
Former positions of Mark DePristo
| Companies | Position | End |
|---|---|---|
The Broad Institute, Inc.
 The Broad Institute, Inc. BiotechnologyHealth Technology The Broad Institute, Inc. engages in the provision of research and development in biomedicals to cure infectious disease. Its scientific areas include chemical biology and therapeutics, genome regulation, cellular circuity and epigenomics, medical and population genetics, and metabolism. The company was founded by Eric S. Lander, Eli Broad and Edythe Broad in 2003 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
| Massachusetts Institute of Technology | Corporate Officer/Principal | - |
SynapDx Corp.
 SynapDx Corp. Miscellaneous Commercial ServicesCommercial Services SynapDx Corp. operates as a laboratory services company which develops a blood-based test for the early detection of autism spectrum disorder. It provides laboratory testing services to physicians who evaluate children for developmental disorders with the initial goal of enabling earlier detection of autism. The company was founded by Stanley N. Lapidus, Jeffrey R. Luber, Graham Gardner and Patrick A. Anquetil in 2010 and is headquartered in Lexington, MA. | Corporate Officer/Principal | - |
Training of Mark DePristo
| University of Cambridge | Doctorate Degree |
| Northwestern University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
SynapDx Corp.
SynapDx Corp. Miscellaneous Commercial ServicesCommercial Services SynapDx Corp. operates as a laboratory services company which develops a blood-based test for the early detection of autism spectrum disorder. It provides laboratory testing services to physicians who evaluate children for developmental disorders with the initial goal of enabling earlier detection of autism. The company was founded by Stanley N. Lapidus, Jeffrey R. Luber, Graham Gardner and Patrick A. Anquetil in 2010 and is headquartered in Lexington, MA. | Commercial Services |
The Broad Institute, Inc.
The Broad Institute, Inc. BiotechnologyHealth Technology The Broad Institute, Inc. engages in the provision of research and development in biomedicals to cure infectious disease. Its scientific areas include chemical biology and therapeutics, genome regulation, cellular circuity and epigenomics, medical and population genetics, and metabolism. The company was founded by Eric S. Lander, Eli Broad and Edythe Broad in 2003 and is headquartered in Cambridge, MA. | Health Technology |
BigHat Biosciences, Inc.
BigHat Biosciences, Inc. Pharmaceuticals: MajorHealth Technology BigHat Biosciences, Inc. operates as an early-stage biotechnology company. The firm focuses on designing antibodies and other therapeutic proteins using artificial intelligence and machine learning techniques. The company was founded by Mark DePristo and Peyton Greenside in 2019 and is headquartered in San Carlos, CA. | Health Technology |
- Stock Market
- Insiders
- Mark DePristo